Self-assembled Apt-AuNP-GO nanocomposites can be used to selectively target MUC1-positive (type I Trans membrane mucin glycoprotein) human breast cancer cells (MCF-7), due to the interaction of MUC1-binding-aptamers and the MUC1 on cell membranes. This evidence concerns the gene MUC1 and breast cancer.